Health and Healthcare
Short Interest Remains Mixed in Major Biotechs
Published:
Last Updated:
The short interest data are out for the December 15 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can make or break them. A single failed clinical trial can mean disaster for a stock. 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies.
The December 15 short interest data have been compared with the previous report, and short interest continued to be mixed in these selected stocks for this settlement date.
Amgen Inc. (NASDAQ: AMGN) saw its short interest rise to 8.35 million shares from the previous level of 7.99 million. Shares closed most recently at $163.55, in a 52-week trading range of $130.09 to $181.81.
Biogen Inc. (NASDAQ: BIIB) had its short interest fall to 2.57 million shares from the previous 2.69 million. Shares closed most recently at $302.29, within a 52-week range of $254.00 to $480.18.
Celgene Corp. (NASDAQ: CELG) short interest for this settlement date decreased to 9.20 million shares from the previous 9.57 million. Shares of Celgene closed most recently at $122.14, in a 52-week range of $92.98 to $140.72.
Gilead Sciences Inc. (NASDAQ: GILD) saw its short interest rise slightly to 25.25 million shares from 25.17 million in the previous period. Shares closed most recently at $103.58, in a 52-week trading range of $86.00 to $123.37.
MannKind Corp. (NASDAQ: MNKD) saw its short interest increase to 111.52 million shares. The previous reading was 110.79 million. Shares closed most recently at $1.53, in a 52-week trading range of $1.38 to $7.88.
Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) short interest decreased to 5.97 million, compared to the previous level of 6.71 million. The mid-June level was far and away the highest reading on the year, and since that time shares have backed off significantly. Shares closed most recently at $189.41, in a 52-week range of $142.02 to $208.88.
The #1 Thing to Do Before You Claim Social Security (Sponsor)
Choosing the right (or wrong) time to claim Social Security can dramatically change your retirement. So, before making one of the biggest decisions of your financial life, it’s a smart idea to get an extra set of eyes on your complete financial situation.
A financial advisor can help you decide the right Social Security option for you and your family. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you.
Click here to match with up to 3 financial pros who would be excited to help you optimize your Social Security outcomes.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
